Edition:
United States

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

61.23USD
9 Dec 2016
Change (% chg)

$1.11 (+1.85%)
Prev Close
$60.12
Open
$60.49
Day's High
$61.51
Day's Low
$60.45
Volume
3,197,171
Avg. Vol
3,207,971
52-wk High
$65.45
52-wk Low
$47.97

Frazier, Kenneth 

Mr. Kenneth C. Frazier is Chairman of the Board, President, Chief Executive Officer of Merck & Co., Inc. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company (2009 to 2010) and Merck Sharp & Dohme Corp. (2007 to 2009). Mr. Frazier also served as Executive Vice President and General Counsel (2006 to 2007) of Merck Sharp & Dohme Corp. (formerly known as Merck & Co., Inc.). Director, Exxon Mobil Corporation since 2009 and Pharmaceutical Research and Manufacturers of America (PhRMA) since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Basic Compensation

Total Annual Compensation, USD 4,902,000
Restricted Stock Awards, USD 9,912,970
Long-Term Incentive Plans, USD --
All Other, USD 9,393,120
Fiscal Year Total, USD 24,208,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 38,622 918,315.00